Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Change in Inventory: 2016-2024

Historic Change in Inventory for UroGen Pharma (URGN) over the last 8 years, with Dec 2024 value amounting to $3.6 million.

  • UroGen Pharma's Change in Inventory rose 698.03% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $747,000, marking a year-over-year decrease of 71.18%. This contributed to the annual value of $3.6 million for FY2024, which is 163.65% up from last year.
  • Per UroGen Pharma's latest filing, its Change in Inventory stood at $3.6 million for FY2024, which was up 163.65% from $1.3 million recorded in FY2023.
  • UroGen Pharma's Change in Inventory's 5-year high stood at $3.6 million during FY2024, with a 5-year trough of $362,000 in FY2022.
  • Over the past 3 years, UroGen Pharma's median Change in Inventory value was $1.3 million (recorded in 2023), while the average stood at $1.8 million.
  • In the last 5 years, UroGen Pharma's Change in Inventory crashed by 87.38% in 2022 and then skyrocketed by 272.38% in 2023.
  • Over the past 5 years, UroGen Pharma's Change in Inventory (Yearly) stood at $2.0 million in 2020, then skyrocketed by 46.03% to $2.9 million in 2021, then plummeted by 87.38% to $362,000 in 2022, then soared by 272.38% to $1.3 million in 2023, then soared by 163.65% to $3.6 million in 2024.